Moreover, the upregulation of miR26a could restore Enz sensitivity in vitro and in vivo, synergistically suppressing tumor growth, bone metastasis, and secondary metastasis by regulating the EZH2/SFRP1/WNT5A axis. The gene discussed is EZH2; the disease is neoplasm.